HK Stock MarketDetailed Quotes

01873 VIVA BIOTECH

Watchlist
  • 0.620
  • +0.010+1.64%
Market Closed Sep 13 16:08 CST
1.34BMarket Cap-10508P/E (TTM)

VIVA BIOTECH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
-14.04%981.82M
-9.42%2.16B
3.02%1.14B
13.10%2.38B
8.02%1.11B
201.90%2.1B
419.57%1.03B
115.74%696.96M
38.79%197.56M
53.81%323.06M
Operating income
-14.04%981.82M
-9.42%2.16B
3.02%1.14B
13.10%2.38B
8.02%1.11B
201.90%2.1B
419.57%1.03B
115.74%696.96M
38.79%197.56M
53.81%323.06M
Cost of sales
12.71%-642.68M
9.39%-1.42B
3.61%-736.22M
-7.63%-1.56B
-7.55%-763.78M
-270.60%-1.45B
-628.84%-710.18M
-134.53%-392.09M
-38.31%-97.44M
-59.87%-167.18M
Operating expenses
12.71%-642.68M
9.39%-1.42B
3.61%-736.22M
-7.63%-1.56B
-7.55%-763.78M
-270.60%-1.45B
-628.84%-710.18M
-134.53%-392.09M
-38.31%-97.44M
-59.87%-167.18M
Gross profit
-16.46%339.15M
-9.47%738.43M
17.68%405.97M
25.30%815.68M
9.07%344.97M
113.53%650.98M
215.90%316.28M
95.59%304.87M
39.26%100.12M
47.81%155.87M
Selling expenses
20.54%-57.56M
-1.33%-132.55M
-29.57%-72.44M
-39.19%-130.8M
-61.04%-55.91M
-617.63%-93.97M
-1,679.40%-34.72M
-266.70%-13.1M
-6.21%-1.95M
9.02%-3.57M
Administrative expenses
10.80%-117.21M
-1.26%-277.11M
7.79%-131.4M
-20.92%-273.65M
-41.94%-142.5M
-105.43%-226.31M
-170.98%-100.39M
-115.10%-110.16M
-65.70%-37.05M
-100.25%-51.22M
Research and development expenses
44.16%-42.83M
5.79%-127.97M
-87.45%-76.7M
-47.04%-135.84M
-9.18%-40.92M
-39.89%-92.38M
-67.87%-37.48M
-46.91%-66.04M
-42.96%-22.32M
-78.03%-44.95M
Revaluation surplus
353.17%64.43M
145.93%162.64M
238.90%14.22M
-293.35%-354.13M
-117.28%-10.24M
71.26%183.15M
-11.11%59.25M
-50.86%106.94M
38.39%66.66M
218.70%217.63M
-Changes in the fair value of financial assets
353.17%64.43M
96.79%-11.68M
238.90%14.22M
-897.31%-364.18M
-117.28%-10.24M
-57.29%45.68M
-11.11%59.25M
-50.86%106.94M
38.39%66.66M
218.70%217.63M
-Changes in the fair value of other assets
----
1,634.56%174.32M
----
-92.69%10.05M
----
--137.48M
----
----
----
----
Impairment and provision
-743.71%-4.69M
13.65%-8.13M
88.57%-556K
-566.03%-9.41M
-4,482.88%-4.87M
53.35%-1.41M
125.58%111K
-67.16%-3.03M
67.22%-434K
-1,503.54%-1.81M
-Other impairment is provision
-743.71%-4.69M
13.65%-8.13M
88.57%-556K
-566.03%-9.41M
-4,482.88%-4.87M
53.35%-1.41M
125.58%111K
-67.16%-3.03M
67.22%-434K
-1,503.54%-1.81M
Operating interest expense
----
----
----
----
7.28%-89.1M
----
---96.1M
-2,648.08%-62.13M
----
-305.92%-2.26M
Special items of operating profit
347.77%35.58M
-25.95%-234.7M
80.85%-14.36M
-268.24%-186.34M
-363.39%-74.97M
225.95%110.76M
5.31%28.47M
-25.27%33.98M
76.17%27.03M
454.68%45.47M
Operating profit
73.86%216.87M
143.95%120.63M
269.65%124.74M
-151.71%-274.49M
-154.29%-73.52M
177.44%530.81M
2.55%135.42M
-39.29%191.33M
41.39%132.05M
149.10%315.16M
Financing cost
64.37%-31.35M
4.38%-176.58M
---87.98M
-0.86%-184.67M
----
---183.11M
----
----
---38.59M
----
Share of profit from joint venture company
----
----
----
----
----
----
----
---487K
---321K
----
Special items of earning before tax
----
----
----
----
175.19%10.05M
----
97.83%-13.37M
-1,497.78%-547.05M
-1,697.79%-615.53M
-65.74%-34.24M
Earning before tax
404.78%185.52M
87.81%-55.95M
157.90%36.75M
-232.06%-459.17M
-152.00%-63.47M
197.61%347.7M
123.36%122.05M
-226.80%-356.21M
-983.08%-522.39M
165.37%280.93M
Tax
-78.75%-41.28M
2.70%-43.84M
-6.19%-23.09M
4.43%-45.06M
17.16%-21.75M
-108.04%-47.14M
-233.19%-26.25M
-50.53%-22.66M
37.76%-7.88M
1.69%-15.05M
After-tax profit from continuing operations
955.99%144.24M
80.21%-99.79M
116.03%13.66M
-267.76%-504.22M
-188.95%-85.22M
179.33%300.56M
118.07%95.8M
-242.50%-378.87M
-1,240.47%-530.27M
193.62%265.87M
Earning after tax
955.99%144.24M
80.21%-99.79M
116.03%13.66M
-267.76%-504.22M
-188.95%-85.22M
179.33%300.56M
118.07%95.8M
-242.50%-378.87M
-1,240.47%-530.27M
193.62%265.87M
Minority profit
116.90%27.43M
-32.70%16.32M
111.44%12.65M
86.38%24.26M
-44.53%5.98M
62.47%13.01M
--10.78M
--8.01M
----
----
Profit attributable to shareholders
11,430.90%116.81M
78.03%-116.11M
101.11%1.01M
-283.79%-528.48M
-207.27%-91.2M
174.32%287.55M
116.03%85.02M
-245.51%-386.88M
-1,240.47%-530.27M
193.62%265.87M
Basic earnings per share
4,900.00%0.05
78.57%-0.06
102.00%0.001
-286.67%-0.28
-225.00%-0.05
160.00%0.15
110.53%0.04
-231.58%-0.25
-1,050.00%-0.38
137.50%0.19
Diluted earnings per share
4,900.00%0.05
50.00%-0.14
102.00%0.001
-450.00%-0.28
-225.00%-0.05
132.00%0.08
110.53%0.04
-238.89%-0.25
-1,366.67%-0.38
125.00%0.18
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Deloitte & Touche Tohmatsu Certified Public Accountants
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover -14.04%981.82M-9.42%2.16B3.02%1.14B13.10%2.38B8.02%1.11B201.90%2.1B419.57%1.03B115.74%696.96M38.79%197.56M53.81%323.06M
Operating income -14.04%981.82M-9.42%2.16B3.02%1.14B13.10%2.38B8.02%1.11B201.90%2.1B419.57%1.03B115.74%696.96M38.79%197.56M53.81%323.06M
Cost of sales 12.71%-642.68M9.39%-1.42B3.61%-736.22M-7.63%-1.56B-7.55%-763.78M-270.60%-1.45B-628.84%-710.18M-134.53%-392.09M-38.31%-97.44M-59.87%-167.18M
Operating expenses 12.71%-642.68M9.39%-1.42B3.61%-736.22M-7.63%-1.56B-7.55%-763.78M-270.60%-1.45B-628.84%-710.18M-134.53%-392.09M-38.31%-97.44M-59.87%-167.18M
Gross profit -16.46%339.15M-9.47%738.43M17.68%405.97M25.30%815.68M9.07%344.97M113.53%650.98M215.90%316.28M95.59%304.87M39.26%100.12M47.81%155.87M
Selling expenses 20.54%-57.56M-1.33%-132.55M-29.57%-72.44M-39.19%-130.8M-61.04%-55.91M-617.63%-93.97M-1,679.40%-34.72M-266.70%-13.1M-6.21%-1.95M9.02%-3.57M
Administrative expenses 10.80%-117.21M-1.26%-277.11M7.79%-131.4M-20.92%-273.65M-41.94%-142.5M-105.43%-226.31M-170.98%-100.39M-115.10%-110.16M-65.70%-37.05M-100.25%-51.22M
Research and development expenses 44.16%-42.83M5.79%-127.97M-87.45%-76.7M-47.04%-135.84M-9.18%-40.92M-39.89%-92.38M-67.87%-37.48M-46.91%-66.04M-42.96%-22.32M-78.03%-44.95M
Revaluation surplus 353.17%64.43M145.93%162.64M238.90%14.22M-293.35%-354.13M-117.28%-10.24M71.26%183.15M-11.11%59.25M-50.86%106.94M38.39%66.66M218.70%217.63M
-Changes in the fair value of financial assets 353.17%64.43M96.79%-11.68M238.90%14.22M-897.31%-364.18M-117.28%-10.24M-57.29%45.68M-11.11%59.25M-50.86%106.94M38.39%66.66M218.70%217.63M
-Changes in the fair value of other assets ----1,634.56%174.32M-----92.69%10.05M------137.48M----------------
Impairment and provision -743.71%-4.69M13.65%-8.13M88.57%-556K-566.03%-9.41M-4,482.88%-4.87M53.35%-1.41M125.58%111K-67.16%-3.03M67.22%-434K-1,503.54%-1.81M
-Other impairment is provision -743.71%-4.69M13.65%-8.13M88.57%-556K-566.03%-9.41M-4,482.88%-4.87M53.35%-1.41M125.58%111K-67.16%-3.03M67.22%-434K-1,503.54%-1.81M
Operating interest expense ----------------7.28%-89.1M-------96.1M-2,648.08%-62.13M-----305.92%-2.26M
Special items of operating profit 347.77%35.58M-25.95%-234.7M80.85%-14.36M-268.24%-186.34M-363.39%-74.97M225.95%110.76M5.31%28.47M-25.27%33.98M76.17%27.03M454.68%45.47M
Operating profit 73.86%216.87M143.95%120.63M269.65%124.74M-151.71%-274.49M-154.29%-73.52M177.44%530.81M2.55%135.42M-39.29%191.33M41.39%132.05M149.10%315.16M
Financing cost 64.37%-31.35M4.38%-176.58M---87.98M-0.86%-184.67M-------183.11M-----------38.59M----
Share of profit from joint venture company -------------------------------487K---321K----
Special items of earning before tax ----------------175.19%10.05M----97.83%-13.37M-1,497.78%-547.05M-1,697.79%-615.53M-65.74%-34.24M
Earning before tax 404.78%185.52M87.81%-55.95M157.90%36.75M-232.06%-459.17M-152.00%-63.47M197.61%347.7M123.36%122.05M-226.80%-356.21M-983.08%-522.39M165.37%280.93M
Tax -78.75%-41.28M2.70%-43.84M-6.19%-23.09M4.43%-45.06M17.16%-21.75M-108.04%-47.14M-233.19%-26.25M-50.53%-22.66M37.76%-7.88M1.69%-15.05M
After-tax profit from continuing operations 955.99%144.24M80.21%-99.79M116.03%13.66M-267.76%-504.22M-188.95%-85.22M179.33%300.56M118.07%95.8M-242.50%-378.87M-1,240.47%-530.27M193.62%265.87M
Earning after tax 955.99%144.24M80.21%-99.79M116.03%13.66M-267.76%-504.22M-188.95%-85.22M179.33%300.56M118.07%95.8M-242.50%-378.87M-1,240.47%-530.27M193.62%265.87M
Minority profit 116.90%27.43M-32.70%16.32M111.44%12.65M86.38%24.26M-44.53%5.98M62.47%13.01M--10.78M--8.01M--------
Profit attributable to shareholders 11,430.90%116.81M78.03%-116.11M101.11%1.01M-283.79%-528.48M-207.27%-91.2M174.32%287.55M116.03%85.02M-245.51%-386.88M-1,240.47%-530.27M193.62%265.87M
Basic earnings per share 4,900.00%0.0578.57%-0.06102.00%0.001-286.67%-0.28-225.00%-0.05160.00%0.15110.53%0.04-231.58%-0.25-1,050.00%-0.38137.50%0.19
Diluted earnings per share 4,900.00%0.0550.00%-0.14102.00%0.001-450.00%-0.28-225.00%-0.05132.00%0.08110.53%0.04-238.89%-0.25-1,366.67%-0.38125.00%0.18
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Deloitte & Touche Tohmatsu Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data